ArticlePloS one2026

Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4-5 patients.

Niilo Liuhto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.